Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.
about
When to recommend a second autograft in patients with relapsed myeloma?The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): stu
P2860
Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Re-invigorating rather than re ...... ma in the era of novel agents.
@en
Re-invigorating rather than re ...... ma in the era of novel agents.
@en-gb
Re-invigorating rather than re ...... ma in the era of novel agents.
@nl
type
label
Re-invigorating rather than re ...... ma in the era of novel agents.
@en
Re-invigorating rather than re ...... ma in the era of novel agents.
@en-gb
Re-invigorating rather than re ...... ma in the era of novel agents.
@nl
prefLabel
Re-invigorating rather than re ...... ma in the era of novel agents.
@en
Re-invigorating rather than re ...... ma in the era of novel agents.
@en-gb
Re-invigorating rather than re ...... ma in the era of novel agents.
@nl
P2860
P356
P1476
Re-invigorating rather than re ...... ma in the era of novel agents.
@en
P2860
P2888
P304
P356
10.1038/BMT.2015.175
P407
P50
P577
2015-08-03T00:00:00Z